Wearable Data for Personalized Prognost… | Clinical Trial

Key information

Conditions

Hematopoietic Neoplasm Hematologic Diseases Hematologic Neoplasms Hematopoietic and Lymphatic System Neoplasm Hemic and Lymphatic Diseases Lymphatic System Neoplasm Malignant Solid Neoplasm Neoplasms Neoplasms by Site

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

About this study

This study will have two distinct stages. Stage 1 will examine and refine the utility and feasibility of the Apple Health-Epic platform in a small, convenience-driven patient cohort to ensure platform robustness and patient feasibility prior to initiating larger recruitment efforts in Stage 2. The objectives of Stage 2 will be to conduct enterprise-wide enrollment to build a large registry database permitting investigation of future specific questions that will be addressed in subsequent retrospective research protocols linked to this registry protocol.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Age: ≥ 18 years
Has Apple Health app on personal device with valid iOS operating software (i.e., iOS 15.0 or higher)
Has a registered MyChart/MyCityofHope account (or be willing to register for one) and the app downloaded onto the personal device that also contains the Apple Health app with their data
Ability to read and understand English to review MyChart/MyCityofHope on-screen instructions to sync and share Apple Health data
Meets one of the below criteria:
Any patient at City of Hope who had and/or has a cancer-related visit (e.g., high risk, newly diagnosed, receiving treatment, active follow-up, survivorship etc.)
City of Hope employee

Exclusion criteria

Prospective participants who, in the opinion of the investigator, may not be able to comply with all study procedures (including compliance issues related to feasibility/logistics)
City of Hope employees listed on the study roster or who manage employees listed on the study roster

Treatment and study plan

Non-Interventional Study

Other

Non-Interventional Study

Other names: Non-Interventional Observational Study, non-interventional study, Noninterventional (Observational) Study

Primary outcomes

Feasibility of data collection

Time frame: Up to 8.5 years

The proportion of participants for whom a successful data connection is established between their Apple Health data and the study registry will be quantified". Then for each variable captured by Apple Health, we will quantify the following feasibility metrics for data collection, evaluated separately for the retrospective (up to 8 years) and prospective (up to 5 years) data periods:

For each subject, the total amount of retrospective (and prospective) HealthKit data available per patient in days and months will be calculated.

For each subject, the number of days per week that a variable is available will be estimated and summarized by the average and standard deviation across weeks (or months).

For both 1-2, the metrics will be calculated when pooling all available data, and separately for windows of 6 months. We will examine histograms and boxplots of the distributions across the cohort.

Study contacts

Contact information is provided by the study sponsor or research team.

Lee Jones

CONTACT

[email protected]

626-761-2214

Sponsors and collaborators

Lead sponsor

City of Hope Medical Center

Other

Registry information

Important dates

Study start: 2026
Primary completion: 2028
Study completion: 2034
First posted: Jul 8, 2026
Registry last updated: Jul 8, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting